Toll Free Number Toll Free: 1800 103 1369 Email Us Email Us: customercare@canmoney.in

Markets

Market

MANKIND PHARMA LTD.

  • NSE CodeMANKINDEQ
  • BSE Code543904
  • ISININE634S01028
  • IndustryPharmaceuticals


Company Information

Management

Mr. Hitesh Kumar Jain

Co. Secretary & Compl. Officer

Mr. Ashutosh Dhawan

Global Chief Financial Officer

Mr. Arjun Juneja

Chief Operating Officer

Dr. Anil Kumar

Chief Scientific Officer

Incorporation Year

03/07/1991

Registered Address

Registered Office : 208, Okhla Industrial Estate, Phase-III,
New Delhi, Delhi - 110020
Tel: 011-47476600

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

investors@mankindpharma.com

Website

http://www.mankindpharma.com

Listing

BSE, NSE

Corporate News

Mankind Pharma - Analysts/Institutional Investor Meet...

30-Oct-2026|3:19PM

Mankind Pharma Limited has informed the Exchange about Transcript

Mankind Pharma - Announcement under Regulation 30 (LO...

30-Oct-2026|3:17PM

Please find attached transcript of the Earnings Conference Call for Q2 & H1

Mankind Pharma - Credit Rating

29-Oct-2026|8:30PM

Mankind Pharma Limited has informed the Exchange about Credit Rating

Mankind Pharma - Announcement under Regulation 30 (LO...

29-Oct-2026|8:27PM

Please find attached intimation regarding re-affirmation/withdrawl of Credi

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug106.26301.29
Aarti Drug435.203,972.07
Aarti Pharma872.707,913.63
Abbott India25,635.0054,472.59
Accent Micro639.001,532.90
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
SBI Large Cap..1019.781.95
Nippon India ..976.481.95
HDFC Large Ca..685.911.84
Nippon India ..534.461.04
Aditya Birla ..518.881.85
More

Board Meetings

DatePurpose
26/10/2026Quarterly Results
30/07/2026Quarterly Results
19/05/2026Audited Results
03/02/2026Quarterly Results
06/11/2025Quarterly Results
More